Ginkgo bioworks announces participation in the 42nd annual j.p. morgan healthcare conference

Boston , jan. 3, 2024 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced that co-founder and ceo, jason kelly, is scheduled to present at the 42nd annual j.p. morgan healthcare conference on wednesday, january 10, 2024 at 9:45 a.m.
DNA Ratings Summary
DNA Quant Ranking